# 21DIF039: Prone to Supine Breast MRI II, P2S2 Breast MRI Trial

> **NCT05131607** · NA · UNKNOWN · sponsor: **Dartmouth-Hitchcock Medical Center** · enrollment: 45 (actual)

## Conditions studied

- Breast Cancer Female

## Interventions

- **PROCEDURE:** Supine MRI

## Key facts

- **NCT ID:** NCT05131607
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-17
- **Primary completion:** 2023-07-03
- **Final completion:** 2024-03-31
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2024-01-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05131607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05131607, "21DIF039: Prone to Supine Breast MRI II, P2S2 Breast MRI Trial". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05131607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*